drugset / Trial / NCT01150123
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women
RandomizedParallel-groupSingle-blindPrevention
Summary
This study will evaluate the safety and immunogenicity of a Group B Streptococcus vaccine.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-11
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Group B streptococcus (GBS) vaccine | Vaccine | 5 ug | — |
| Subject | Group B streptococcus (GBS) vaccine | Vaccine | 20 ug | — |